Skip to main content

Table 1 Clinical and pathological data of obese breast cancer patients

From: Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity

Characteristic Non-IBC
(N = 31)
IBC
(N = 13)
P value
Age (years)
 Range 36-71 30-69 0.656ª
 Mean ± SEM 48.5 ± 1.5 46.23 ± 4.68
Tumour size (cm)
 ≤ 4 14 (45.2%) 6 (60%) 1b
 > 4 8 (25.8%) 4 (40%)
 NA 9 3
Lymph node status, n (%)
 ≤ 4 19 (61.3%) 6 (50%) 0.29b
 > 4 8 (25.8%) 6 (50%)
 NA 4 1
Tumour grade, n (%)
 G1 0 0 0.65b
 G2 23 (74.2%) 12 (92.3%)
 G3 4 (12.9%) 1 (7.7%)
 NA 4 0
Lymphovascular invasion, n (%)
 Negative 10 (32.3%) 4 (40%) 0.7b
 Positive 9 (29%) 6 (60%)
 NA 12 3
ER, n (%)
 Negative 4 (12.9%) 2 (15.38%) 1b
 Positive 26 (83.9%) 11 (84.62%)
 NA 1 0
PR, n (%)
 Negative 5 (16.1%) 3 (23.08%) 0.68b
 Positive 25 (80.6%) 10 (76.92%)
 NA 1 0
HER-2, n (%)
 Negative 23 (74.2%) 8 (61.54%) 1b
 Positive 7 (22.6%) 5 (38.46%)
 NA 1 0
  1. Data are expressed as mean ± SEM
  2. NA not available
  3. *significant P-value calculated by ªStudent’s t-test or bPearson Chi-Square